DalsnaFinance › IPOs › Bicara Therapeutics Inc.
Bicara Therapeutics Inc. completed its initial public offering on NASDAQ on September 13, 2024, pricing at $18.00 a share.
| Ticker | BCAX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 13, 2024 |
| Offering price | $18.00 |
| Shares offered | 17,500,000 |
| Total raised | $315M |
Bicara Therapeutics Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.